BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moonmuang S, Chaiyawat P, Jantrapirom S, Pruksakorn D, Lo Piccolo L. Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma. Cancers 2021;13:4214. [DOI: 10.3390/cancers13164214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Corral A, Alcala M, Carmen Duran-ruiz M, Arroba AI, Ponce-gonzalez JG, Todorčević M, Serra D, Calderon-dominguez M, Herrero L. Role of long non-coding RNAs in adipose tissue metabolism and associated pathologies. Biochemical Pharmacology 2022;206:115305. [DOI: 10.1016/j.bcp.2022.115305] [Reference Citation Analysis]
2 Smolkova B, Kataki A, Earl J, Ruz-caracuel I, Cihova M, Urbanova M, Buocikova V, Tamargo S, Rovite V, Niedra H, Schrader J, Kohl Y. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103865] [Reference Citation Analysis]
3 Chellini L, Palombo R, Riccioni V, Paronetto MP. Oncogenic Dysregulation of Circulating Noncoding RNAs: Novel Challenges and Opportunities in Sarcoma Diagnosis and Treatment. Cancers 2022;14:4677. [DOI: 10.3390/cancers14194677] [Reference Citation Analysis]
4 Aryee DNT, Fock V, Kapoor U, Radic-sarikas B, Kovar H. Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis. Cells 2022;11:1267. [DOI: 10.3390/cells11081267] [Reference Citation Analysis]
5 Lee AM, Ferdjallah A, Moore E, Kim DC, Nath A, Greengard E, Huang RS. Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma. Int J Mol Sci 2021;22:11168. [PMID: 34681828 DOI: 10.3390/ijms222011168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]